Log In
Print
BCIQ
Print
Print this Print this
 

Cerdulatinib (PRT062070, PRT2070)

  Manage Alerts
Collapse Summary General Information
Company Portola Pharmaceuticals Inc.
DescriptionDual inhibitor of spleen tyrosine kinase (SYK) and JAK kinase (JAK)
Molecular Target Spleen tyrosine kinase (SYK) ; JAK kinase (JAK)
Mechanism of ActionKinase inhibitor; Syk kinase inhibitor; Janus kinase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today